BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 84 filers reported holding BICYCLE THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is 16.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $281,478 | -79.6% | 13,907 | -74.9% | 0.00% | – |
| Q1 2024 | $1,380,705 | +197.0% | 55,450 | +204.4% | 0.00% | – |
| Q2 2023 | $464,847 | +107.2% | 18,215 | +72.7% | 0.00% | – |
| Q1 2023 | $224,356 | -90.6% | 10,548 | -86.9% | 0.00% | -100.0% |
| Q4 2022 | $2,384,369 | +97260.9% | 80,553 | -23.5% | 0.00% | 0.0% |
| Q3 2022 | $2,449 | -5.4% | 105,291 | -31.8% | 0.00% | 0.0% |
| Q2 2022 | $2,590 | -100.0% | 154,326 | -5.5% | 0.00% | -50.0% |
| Q1 2022 | $7,164,000 | +469.0% | 163,265 | +689.2% | 0.00% | – |
| Q4 2021 | $1,259,000 | +103.7% | 20,687 | +39.2% | 0.00% | – |
| Q3 2021 | $618,000 | – | 14,863 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 917,218 | $40,248,000 | 48.61% |
| GREAT POINT PARTNERS LLC | 550,592 | $24,160,000 | 5.84% |
| Logos Global Management LP | 950,000 | $41,686,000 | 5.40% |
| Deep Track Capital, LP | 1,855,993 | $81,441,000 | 5.22% |
| First Light Asset Management, LLC | 890,174 | $39,061,000 | 3.44% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,154,126 | $50,643,000 | 3.00% |
| Ikarian Capital, LLC | 478,784 | $21,009,000 | 2.76% |
| Opaleye Management Inc. | 175,000 | $7,679,000 | 2.38% |
| Frazier Life Sciences Management, L.P. | 603,521 | $26,483,000 | 2.26% |
| Altium Capital Management LP | 120,000 | $5,266,000 | 1.76% |